Followers | 28 |
Posts | 1145 |
Boards Moderated | 0 |
Alias Born | 11/05/2020 |
![](https://investorshub.advfn.com/uicon/763599.png?cb=1629814148)
Sunday, June 12, 2022 3:12:40 PM
The IND is for TCellVax (which was already under an IND).
TCellVax didn't make it to phase 1 not because of missing mRNA but because there was nothing to bring to phase 1.
Stop and think for a second.... Why didn't it go to phase 1 when it first received an IND in 2016? For not having "mRNA" for "easier administration?"
mRNA missing isn't going to make it go to phase 1. It has nothing to do with what TCellVax is functionally (physiologically).
But I hope people keep waiting on phase 1.
Koos certainly knows what he is doing. mRNA is a hot topic.
After all, Regen has brought how many drugs to phase 1 from it's inception in 2012?
NONE.
He can't/won't hire a CSO. But he's going to have a drug in phase 1 clinical trials? By himself? LOL
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM